 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CEL-SCI (NYSE:CVM  Get Free Report) and Axcella Health (NASDAQ:AXLA  Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two...

#038; Axcella Health (NASDAQ:AXLA)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Axcella Health trading halted, volatility trading pause

Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic...

Axcella Announces Reverse Stock Split Effective September 19, 2023

Axcella Health Inc. (NASDAQ:AXLA  Get Free Report)s share price traded down 15.2% during mid-day trading on Wednesday . The stock traded as low as $0.32 and last traded at $0.38...

Axcella Health (NASDAQ:AXLA) Trading Down 15.2%

Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps? Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps? PR Newswire NEW...

Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps?

Cyclo Therapeutics (NASDAQ:CYTH Get Free Report) and Axcella Health (NASDAQ:AXLA Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, ...

Critical Analysis: Axcella Health (NASDAQ:AXLA) & Cyclo Therapeutics (NASDAQ:CYTH)

Axcella Granted Patent for Long COVID Fatigue Treatment

Axcella Health (NASDAQ:AXLA Get Free Report) and Monte Rosa Therapeutics (NASDAQ:GLUE Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, ...

Head to Head Comparison: Axcella Health (NASDAQ:AXLA) vs. Monte Rosa Therapeutics (NASDAQ:GLUE)

Gainers
Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.

read more...

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Axcella Health Inc. (NASDAQ:AXLA Free Report) Analysts at HC Wainwright lifted their FY2023 earnings estimates for shares of Axcella Health in a research note issued to investors on Monday, August 7th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings per share of ($0....

FY2023 EPS Estimates for Axcella Health Inc. Boosted by HC Wainwright (NASDAQ:AXLA)

Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.

Watchers	2,954
52-Wk Low	$2.00
52-Wk High	$41.25

Market Cap	$2.89M
Volume (M)	46,451.00
52-Wk High	$41.25
52-Wk Low	$2.00

AXLA Axcella Health Inc

About

Feed

News

Sentiment

Earnings

Fundamentals